Laporan Laba Rugi APLLTD - TTM - Alembic Pharmaceuticals Limited

Laporan Laba Rugi (TTM)

Laporan Laba Rugi Alembic Pharmaceuticals Limited menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

	2020 09-30	2020 12-31	2021 03-31	2021 06-30	2021 09-30	2021 12-31	2022 03-31	2022 06-30	2022 09-30	2022 12-31	2023 03-31	2023 06-30	2023 09-30	2023 12-31	2024 03-31	2024 06-30	2024 09-30	2024 12-31	2025 03-31	2025 06-30
Revenue	52,144	53,196	53,931	53,778	52,131	51,704	53,058	52,419	54,246	56,619	56,526	58,766	59,966	61,181	62,286	63,042	63,573	64,194	66,721	68,211
Change (%)		2.02	1.38	-0.28	-3.06	-0.82	2.62	-1.20	3.49	4.37	-0.16	3.96	2.04	2.03	1.81	1.21	0.84	0.98	3.94	2.23
% of Revenue	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00

Cost Of Sales	12,632	12,577	13,402	13,875	14,084	14,581	14,982	14,396	16,015	17,139	17,748	18,100	18,284	18,342	17,961	17,768	17,444	17,232	18,808	18,941
Change (%)		-0.44	6.56	3.53	1.51	3.53	2.75	-3.91	11.25	7.01	3.55	1.99	1.02	0.31	-2.08	-1.08	-1.82	-1.22	9.14	0.71
% of Revenue	24.22	23.64	24.85	25.80	27.02	28.20	28.24	27.46	29.52	30.27	31.40	30.80	30.49	29.98	28.84	28.18	27.44	26.84	28.19	27.77

Gross Operating Profit	39,512	40,619	40,529	39,903	38,046	37,123	38,076	38,023	38,231	39,480	38,778	40,666	41,681	42,839	45,136	45,274	46,128	46,962	47,913	49,270
Change (%)		2.80	-0.22	-1.54	-4.65	-2.43	2.57	-0.14	0.55	3.27	-1.78	4.87	2.50	2.78	5.36	0.31	1.89	1.81	2.02	2.83
% of Revenue	75.78	76.36	75.15	74.20	72.98	71.80	71.76	72.54	70.48	69.73	68.60	69.20	69.51	70.02	72.46	71.82	72.56	73.16	71.81	72.23

SG&A	10,283	10,638	10,514	10,678	10,848	10,951	11,382	11,335	11,354	11,540	11,755	12,332	12,904	13,484	14,492	14,808	15,252	15,734	15,676	16,106
Change (%)		3.46	-1.17	1.56	1.60	0.95	3.94	-0.41	0.16	1.64	1.86	4.91	4.64	4.49	7.47	2.18	3.00	3.16	-0.37	2.74
% of Revenue	19.72	20.00	19.49	19.85	20.81	21.18	21.45	21.62	20.93	20.38	20.80	20.99	21.52	22.04	23.27	23.49	23.99	24.51	23.50	23.61

R&D
Change (%)
% of Revenue

OpEx	38,366	39,069	40,963	42,641	42,963	43,721	47,183	48,876	50,891	53,300	52,148	52,539	53,982	55,050	55,679	56,082	56,332	57,020	59,423	60,515
Change (%)		1.83	4.85	4.10	0.76	1.76	7.92	3.59	4.12	4.73	-2.16	0.75	2.75	1.98	1.14	0.72	0.45	1.22	4.21	1.84
% of Revenue	73.58	73.44	75.95	79.29	82.41	84.56	88.93	93.24	93.81	94.14	92.26	89.40	90.02	89.98	89.39	88.96	88.61	88.82	89.06	88.72

Operating Income	13,778	14,127	12,968	11,137	9,167	7,983	5,875	3,543	3,355	3,320	4,378	6,227	5,984	6,130	6,607	6,960	7,241	7,174	7,298	7,696
Change (%)		2.53	-8.20	-14.12	-17.69	-12.92	-26.41	-39.68	-5.31	-1.06	31.88	42.25	-3.91	2.45	7.78	5.34	4.03	-0.93	1.73	5.45
% of Revenue	26.42	26.56	24.05	20.71	17.59	15.44	11.07	6.76	6.19	5.86	7.74	10.60	9.98	10.02	10.61	11.04	11.39	11.18	10.94	11.28

Interest Expense	-263	-212	-160	-115	-116	-136	-177	-244	-322	-425	-502	-558	-590	-596	-562	-550	-581	-652	-788	-891
Change (%)		-19.23	-24.47	-28.46	0.96	17.46	30.46	37.68	32.04	31.86	18.05	11.16	5.88	0.97	-5.75	-2.15	5.67	12.20	20.83	13.13
% of Revenue	-0.50	-0.40	-0.30	-0.21	-0.22	-0.26	-0.33	-0.47	-0.59	-0.75	-0.89	-0.95	-0.98	-0.97	-0.90	-0.87	-0.91	-1.02	-1.18	-1.31

Net Income	10,936	11,520	11,465	10,412	8,771	7,609	5,209	3,153	2,662	2,113	3,420	5,285	5,317	5,902	6,158	6,299	6,468	6,047	5,834	6,031
Change (%)		5.34	-0.48	-9.19	-15.76	-13.24	-31.54	-39.48	-15.58	-20.60	61.84	54.53	0.61	11.01	4.34	2.29	2.67	-6.50	-3.53	3.37
% of Revenue	20.97	21.66	21.26	19.36	16.82	14.72	9.82	6.01	4.91	3.73	6.05	8.99	8.87	9.65	9.89	9.99	10.17	9.42	8.74	8.84

Source: Capital IQ

Alembic Pharmaceuticals Limited - Laporan Laba Rugi (TTM)

Laporan Laba Rugi (TTM)

Other Listings